GLP-1 Drugs Linked With Chronic Cough​GLP-1 Drugs Linked With Chronic Cough 

People with type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists were more likely to develop chronic cough than people using other second-line medications, a new study found. ​People with type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists were more likely to develop chronic cough than people using other second-line medications, a new study Read More

Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says​Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says 

When endocrinologist Mary Elizabeth Patti looks at a patient with type 2 diabetes who could benefit from weight loss, she sees more than body mass index and blood glucose levels. She also recognizes the challenges of social vulnerability, understanding how low income, food insecurity, and limited access to health care might matter in treatment choice. Read More